Larvol Delta - Black-Diamond-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Study-of-BDTX1535-a-MasterKey-Inhibitor-of-EGFR-for-the-Treatment-of-Glioblastoma-and-NonSmall-Cell-Lung-Cancer

BDTX-1535 - Black Diamond Therap

https://www.globenewswire.com/news-release/2022/04/18/2423594/0/en/Black-Diamond-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Study-of-BDTX-1535-a-MasterKey-Inhibitor-of-EGFR-for-the-Treatment-of-Glioblastoma-and-Non-Small-Cell-Lung-Cance.html

Apr 18, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next